GLP-1 receptor agonist-related neuropsychiatric AEs

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-025-77395-3
中图分类号
学科分类号
摘要
引用
收藏
页码:7 / 7
相关论文
共 50 条
  • [41] The Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide Transiently Delays Gastric Emptying Similarly to a Selective Long-Acting GLP-1 Receptor Agonist
    Urva, Shweta
    Nauck, Michael A.
    Coskun, Tamer
    Cui, Xuewei
    Haupt, Axel
    Benson, Charles
    Loghin, Corina
    DIABETES, 2019, 68
  • [42] The novel dual GIP and GLP-1 receptor agonist, tirzepatide, transiently delays gastric emptying similarly to a selective long-acting GLP-1 receptor agonist
    Urva, S.
    Nauck, M. A.
    Coskun, T.
    Cui, X.
    Haupt, A.
    Benson, C. T.
    Loghin, C.
    DIABETOLOGIA, 2019, 62 : S58 - S58
  • [43] EFFECT OF WEIGHT MANAGEMENT UTILIZING GLP-1 RECEPTOR AGONIST ON NAFLD
    Hefner, Anna Marie
    Pozza, Renee S.
    Barakat, Fatma
    Sweet, Patrick H., III
    Oliver, Deanna
    Hassanein, Tarek I.
    HEPATOLOGY, 2021, 74 : 1006A - 1007A
  • [44] Semaglutide GLP-1 receptor agonist Treatment of type 2 diabetes
    Chudleigh, R.
    Bain, S. C.
    DRUGS OF THE FUTURE, 2017, 42 (08) : 479 - 487
  • [45] Controversies on the effects of GLP-1 receptor agonist treatment on gastric emptying
    Rubio-Herrera, Miguel A.
    Lesmes, Irene Breton
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2025, 72 (02):
  • [46] GLP-1 receptor agonist-induced polyarthritis: a case report
    Maria Luisa Ambrosio
    Matteo Monami
    Lavinia Sati
    Niccolò Marchionni
    Mauro Di Bari
    Edoardo Mannucci
    Acta Diabetologica, 2014, 51 : 673 - 674
  • [47] Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis
    Borner, Tito
    Workinger, Jayme L.
    Tinsley, Ian C.
    Fortin, Samantha M.
    Stein, Lauren M.
    Chepurny, Oleg G.
    Holz, George G.
    Wierzba, Aleksandra J.
    Gryko, Dorota
    Nexo, Ebba
    Shaulson, Evan D.
    Bamezai, Ankur
    Rodriguez Da Silva, Valentina A.
    De Jonghe, Bart C.
    Hayes, Matthew R.
    Doyle, Robert P.
    CELL REPORTS, 2020, 31 (11):
  • [48] Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
    Wharton, Sean
    Blevins, Thomas
    Connery, Lisa
    Rosenstock, Julio
    Raha, Sohini
    Liu, Rong
    Ma, Xiaosu
    Mather, Kieren J.
    Haupt, Axel
    Robins, Deborah
    Pratt, Edward
    Kazda, Christof
    Konig, Manige
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (10): : 877 - 888
  • [49] GLP-1 receptor agonist therapy and pregnancy: Evolving and emerging evidence
    Varughese, Maria S.
    O'Mahony, Fidelma
    Varadhan, Lakshminarayanan
    CLINICAL MEDICINE, 2025, 25 (02)
  • [50] The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy
    Oezer, Kuebra
    Kolibabka, Matthias
    Gassenhuber, Johann
    Dietrich, Nadine
    Fleming, Thomas
    Schlotterer, Andrea
    Morcos, Michael
    Wohlfart, Paulus
    Hammes, Hans-Peter
    ACTA DIABETOLOGICA, 2023, 60 (11) : 1551 - 1565